| pubmed-article:20027664 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20027664 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:20027664 | lifeskim:mentions | umls-concept:C0018801 | lld:lifeskim |
| pubmed-article:20027664 | lifeskim:mentions | umls-concept:C0032105 | lld:lifeskim |
| pubmed-article:20027664 | lifeskim:mentions | umls-concept:C2709270 | lld:lifeskim |
| pubmed-article:20027664 | lifeskim:mentions | umls-concept:C0441781 | lld:lifeskim |
| pubmed-article:20027664 | lifeskim:mentions | umls-concept:C0806140 | lld:lifeskim |
| pubmed-article:20027664 | pubmed:issue | 12 | lld:pubmed |
| pubmed-article:20027664 | pubmed:dateCreated | 2009-12-28 | lld:pubmed |
| pubmed-article:20027664 | pubmed:abstractText | The prognostic role of echocardiography is well established in patients with previous or current symptoms of heart failure (HF). Less is understood about patients with stage B HF, who have structural heart disease but no symptoms at any stage. This study investigated the role of plasma N-terminal protype-B natriuretic peptide (NT-proBNP) and Doppler-echo parameters of diastolic and systolic function for risk stratification in stage B HF patients. | lld:pubmed |
| pubmed-article:20027664 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20027664 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20027664 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20027664 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20027664 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20027664 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20027664 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20027664 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20027664 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:20027664 | pubmed:issn | 1932-8737 | lld:pubmed |
| pubmed-article:20027664 | pubmed:author | pubmed-author:Di... | lld:pubmed |
| pubmed-article:20027664 | pubmed:author | pubmed-author:DoughtyRobert... | lld:pubmed |
| pubmed-article:20027664 | pubmed:author | pubmed-author:RosaGian... | lld:pubmed |
| pubmed-article:20027664 | pubmed:author | pubmed-author:DiniFrank LFL | lld:pubmed |
| pubmed-article:20027664 | pubmed:author | pubmed-author:FontanivePaol... | lld:pubmed |
| pubmed-article:20027664 | pubmed:author | pubmed-author:PoppeKatrinaK | lld:pubmed |
| pubmed-article:20027664 | pubmed:author | pubmed-author:WhalleyGillia... | lld:pubmed |
| pubmed-article:20027664 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:20027664 | pubmed:volume | 32 | lld:pubmed |
| pubmed-article:20027664 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20027664 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20027664 | pubmed:pagination | 711-7 | lld:pubmed |
| pubmed-article:20027664 | pubmed:meshHeading | pubmed-meshheading:20027664... | lld:pubmed |
| pubmed-article:20027664 | pubmed:meshHeading | pubmed-meshheading:20027664... | lld:pubmed |
| pubmed-article:20027664 | pubmed:meshHeading | pubmed-meshheading:20027664... | lld:pubmed |
| pubmed-article:20027664 | pubmed:meshHeading | pubmed-meshheading:20027664... | lld:pubmed |
| pubmed-article:20027664 | pubmed:meshHeading | pubmed-meshheading:20027664... | lld:pubmed |
| pubmed-article:20027664 | pubmed:meshHeading | pubmed-meshheading:20027664... | lld:pubmed |
| pubmed-article:20027664 | pubmed:meshHeading | pubmed-meshheading:20027664... | lld:pubmed |
| pubmed-article:20027664 | pubmed:meshHeading | pubmed-meshheading:20027664... | lld:pubmed |
| pubmed-article:20027664 | pubmed:meshHeading | pubmed-meshheading:20027664... | lld:pubmed |
| pubmed-article:20027664 | pubmed:meshHeading | pubmed-meshheading:20027664... | lld:pubmed |
| pubmed-article:20027664 | pubmed:meshHeading | pubmed-meshheading:20027664... | lld:pubmed |
| pubmed-article:20027664 | pubmed:meshHeading | pubmed-meshheading:20027664... | lld:pubmed |
| pubmed-article:20027664 | pubmed:meshHeading | pubmed-meshheading:20027664... | lld:pubmed |
| pubmed-article:20027664 | pubmed:meshHeading | pubmed-meshheading:20027664... | lld:pubmed |
| pubmed-article:20027664 | pubmed:meshHeading | pubmed-meshheading:20027664... | lld:pubmed |
| pubmed-article:20027664 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:20027664 | pubmed:articleTitle | Plasma N-terminal protype-B natriuretic peptide and restrictive mitral flow to risk-stratify patients with stage B heart failure. | lld:pubmed |
| pubmed-article:20027664 | pubmed:affiliation | Cardiovascular Diseases Unit 2, Santa Chiara Hospital, Pisa, Italy. | lld:pubmed |
| pubmed-article:20027664 | pubmed:publicationType | Journal Article | lld:pubmed |
